Malignancy Workup in Cryptogenic Stroke
This survey of stroke and thrombosis experts found heterogeneity in testing for cancer screening in patients with cryptogenic stroke, with the majority either not screening at all or deferring tests to primary care providers. Our survey highlights the need for better evidence and evidence-based recommendations to guide the approach to cancer screening in this population.
Authors
- Ronda Lun (ORCID: https://orcid.org/0000-0001-8455-8201)
- Dominick Bossé (ORCID: https://orcid.org/0000-0003-2992-5632)
- Brian Dewar (ORCID: https://orcid.org/0000-0002-9222-5420)
- Dar Dowlatshahi (ORCID: https://orcid.org/0000-0003-1379-3612)
- Michel Christopher Frank Shamy (ORCID: https://orcid.org/0000-0002-0085-6816)
- Jamie Brehaut (ORCID: https://orcid.org/0000-0002-4213-1143)
- Deborah M. Siegal (ORCID: https://orcid.org/0000-0003-3806-3245)
- Luc Poirier (ORCID: https://orcid.org/0009-0009-9382-0836)
Institutions
- University of Ottawa (CA)
- Ottawa Hospital (CA)
- Stanford Medicine (US)
- Ottawa Hospital Research Institute (CA)
Publication Details
- Journal
- Neurology Clinical Practice
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1212/cpj.0000000000200477
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00